Peptidergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Peptidergic neurons are neurons that synthesize, store, and release neuropeptides as their primary neurotransmitters. These cells play crucial roles in modulating neural circuits, regulating homeostasis, and influencing neurodegenerative processes.
Peptidergic neurons represent a major class of neuromodulatory cells in the central and peripheral nervous systems. Unlike classical fast-acting neurotransmitters (glutamate, GABA, acetylcholine), neuropeptides act as messengers with slower, longer-lasting effects on target cells.
- Oxytocin - social bonding, trust, stress response
- Vasopressin - water retention, blood pressure, social behavior
- Corticotropin-releasing hormone (CRH) - stress axis activation
- Somatostatin - growth hormone regulation, inhibitory modulator
- Neurotensin - pain modulation, reward pathways
- Adrenocorticotropic hormone (ACTH) - adrenal stimulation
- Melanocyte-stimulating hormone (MSH) - appetite regulation
- Endorphins - natural pain relief, reward
- Substance P - pain transmission, nausea
- Neuropeptide Y (NPY) - appetite, energy balance, anxiety
- Cholecystokinin (CCK) - satiety, anxiety
- Galanin - feeding, sleep, mood
Peptidergic neurons modulate synaptic transmission by:
- Altering ion channel function
- Changing gene expression in target neurons
- Modulating receptor sensitivity
- Regulating network oscillations
These neurons integrate metabolic, osmotic, and stress signals to maintain bodily homeostasis through neuroendocrine pathways.
- Reduced somatostatin levels in AD brains correlate with cognitive decline
- NPY has neuroprotective effects against amyloid-beta toxicity
- CRH dysregulation contributes to stress-related neurodegeneration
- Substance P-containing neurons in the substantia nigra are affected
- Neurotensin pathways interact with dopaminergic signaling
- NPY may modulate nigrostriatal degeneration
- Dysregulation of neuropeptides in motor neuron disease
- Altered Substance P signaling in ALS progression
- Peptidergic neurons interact with microglia
- Axon guidance peptides influence neuroinflammatory responses
- NPY receptor agonists for metabolic disorders
- Substance P antagonists (NK1R) for depression and pain
- Oxytocin for social cognition in neurodegeneration
- Somatostatin receptors as diagnostic markers
- NPY receptors for appetite regulation in dementia
- CRH receptors for stress-related neurodegeneration
The study of Peptidergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bowers CW, et al. Peptidergic neurons. Trends Neurosci. 1984
- Hökfelt T, et al. Neuropeptides: an overview. Neuropharmacology. 2000
- Meyer-Lindenberg A, et al. Oxytocin and vasopressin: social neuropeptides. Nat Rev Neurosci. 2011
- Couzens M, et al. Neuropeptide Y in neurodegeneration. Eur J Pharmacol. 2020
- Sullivan NR, et al. Somatostatin and Alzheimer's disease. Brain Res. 2007